Musely Raises $360M Debt Financing

Musely, a direct-to-consumer telemedicine platform, has secured over $360 million in non-dilutive capital. This round of funding brings their total known funding to over $380 million, including a previous $20 million raised in 2014. The company specializes in compounded treatments for skin, hair, and menopause care, offering prescription products through asynchronous consultations.

Investors

General Catalyst's Customer Value Fund (CVF) provided the non-dilutive capital. CVF offers an alternative financing model similar to a revenue-share agreement, where companies repay funds along with a fixed, capped percentage of revenue generated from the use of the fund, without taking an equity stake or charging interest.

Musely Use of Funds

The capital will be used to support Musely's customer growth, specifically for sales, marketing, and other customer acquisition efforts. The funding aims to provide a war chest to scale the company's reach.

About Musely

Founded in 2014 by co-founder and CEO Jack Jia, Musely initially started as a wellness community before pivoting in 2019 to a prescription skincare platform. The company's mission is to provide access to compounded treatments for skin, hair, and menopause care through a telemedicine platform, connecting patients with board-certified dermatologists and OB-GYNs for asynchronous consultations.

Funding Details

Company: Musely
Raised: $360M
Round: Debt Financing
Funding Date: May 1, 2026
Lead Investor: General Catalyst's Customer Value Fund (CVF)
Software Category: Telemedicine, Digital Health
Company Website: https://musely.com
Source: https://techcrunch.com/2026/05/01/musely-secures-360m-from-general-catalyst-without-giving-up-equity/